ELIZABETH SIBLEY: Open Payments
NPI 1790512176 · LA FOLLETTE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 16 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $157 |
| ABBVIE INC. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, Kerendia, Ozempic, REXULTI, AIRSUPRA, MOUNJARO.
Industry payments across TN — which companies pay providers there.
